
Range and release wording
Confirm the individual amount and whether the selected preparation is immediate or extended release. Dosage form and package are not specified.
Explore pharmacy listings
Review the pregnenolone catalog entry and its IR/ER wording. Confirm the exact ingredient, available strength, dosage form and package with the responsible pharmacy.
Already approved? Sign in to see products and pricing for your practice.
Emerald has one entry named “Pregnenlone 10–50mg (IR/ER).” This source range does not establish every intermediate strength or a complete formulation.
1 source entry. Open a pharmacy to review its listings. Repeated or similar names do not establish distinct products or current availability.
| Source preparation / review note | Listed amount / strength | Package |
|---|---|---|
| Pregnenlone 10-50mg (IR/ER)Confirm individual strength, release, dosage form and package | 10–50 mg range (IR/ER) | Not specified — confirm |
Review the exact product with the responsible pharmacy before submitting an order.
Complete practice and account review to get started.
Review the preparation, pharmacy information and account pricing.
Confirm your cart, order details and applicable requirements.
Use saved carts and order history for repeat purchasing.
Participating pharmacies retain prescription review, dispensing and fulfillment responsibilities.
The treating clinician determines suitability and prescribing. Review the exact product’s labeling and pharmacy information.
Pregnenolone is a steroid hormone precursor studied in biological and clinical research. Its biological role alone does not establish an indication or benefit for a particular preparation.
Published research describes pregnenolone biology. That research does not validate the efficacy, safety or labeling of Emerald’s catalog preparation. The clinician should review the intended use, medical history and exact pharmacy formulation. PubMed: pregnenolone biology research
Confirm the regulatory status of the exact preparation. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
No. The source provides a range, not a list of individual products. Confirm the specific available amount, release characteristics, dosage form and package with Emerald.
This page represents 1 source entries. Some names may overlap; confirm the exact product and current availability through your approved account.
No. Product amounts, concentrations and package quantities describe different specifications. The clinician and dispensing pharmacy determine the prescription and instructions.
Interchangeability is not established by a shared ingredient name, matching concentration or release abbreviation. Review each complete formulation and label.
No approval status is established by catalog inclusion. Compounded preparations are not FDA-approved. Confirm the exact product and regulatory status with the pharmacy.
Ordering and account pricing are available to verified, approved clinic accounts. Patients should discuss prescriptions and treatment with their clinician.
Review the current ingredient list, strength units, dosage form, route, release characteristics, package, availability, storage and applicable pharmacy requirements.
Email info@corelinkpharm.com for platform and account questions. Contact the pharmacy for product-specific information.
Start with account access. Keep product review, pricing and ordering together.